Pre-Purchase Consultation Customer Support Find InBody Test Center

About us

We are InBody, a worldwide leader in body composition technology.

In the early 1990s, founder and CEO, Dr. Kichul Cha, recognised that the available BIA devices were limited and faulty. They were often inaccurate, and from a medical standpoint, useless for treating patients who needed body composition analysis the most. Drawing from his background in mechanical engineering, he set to work to design something better.

In 1996, he founded InBody. Two years later, the first InBody device was born. Today, InBody has grown from a small biotech startup in South Korea to a multinational corporation with branches and distributors in more than 110 countries. Our clients trust us to provide precise, useful, and accurate body composition data to their users because they know that InBody combines convenience, accuracy, and reproducibility in one easy-to-use device.

Mission

“InBody is dedicated to inspiring and leading people to live a healthier life.”

Vision

“It is InBody's vision that one day health should not only be measured by knowing your weight, but by having an accurate insight into your body composition.”

CEO Message — Dr. Kichul Cha

"Since InBody was established in 1996, we have strived to operate as an excellent, 21st-century company by fulfilling our corporate mission of contributing to society with world-leading technology. We will continue to support the growth of society with highly value-added products and services, facing all challenges and meeting your expectations with a deep sense of responsibility. InBody continues to grow day after day, as we don't look for a single big success but are always trying to build on small achievements. InBody is dedicated to inspiring and leading people to live a healthier life. Going forward, we will continue to follow our motto — “Makes Life Better” — while steadfastly adhering to our guiding principles of passion, effort, and innovation."

History of InBody

Early 1990's

Dr. Kichul Cha recognized BIA devices were inaccurate, making them useless to the medical industry.

1996

InBody was founded in South Korea. Products feature direct segmental multi-frequency bioelectrical impedance analysis (DSM-BIA) and an eight-point tactile electrode system to measure an individual's body composition without the use of empirical data.

2000

InBody established its first overseas subsidiary in Beverly Hills, California. InBody technology is FDA-Cleared and results have been validated by research.

2009

GE Healthcare Strategic Business Partnership

2012

InBody moved its corporate office from Beverly Hills to Cerritos, California.

2013

The InBody 570, capable of measuring segmental fat analysis including visceral fat level, is released.

2014

The InBody 770, a new research-grade body composition analyzer is launched and the InBody 570 wins the Red Dot Design Award.

2015

iF DESIGN AWARD is given to the InBody 770. InBody receives the 2015 Foreign Direct Investment Award from the Los Angeles Chamber of Commerce during World Trade Week.

InBody BAND and InLab win CES 2015 Innovation Award for wearable technologies.

InBody unveiled the InBody BAND, the world’s first wearable body composition device.

2016

LookinBodyWeb, a cloud-based data software is launched.

The InBody PUSH, a handheld, portable stadiometer is released for the first time in the United States.

The InBody 270, designed specifically for professionals who need to analyze body composition on-the-go, goes on sale.

2017

InBody releases the InBody BAND 2, a second-generation wearable body composition device. The BAND 2 features EZTraining™, which automatically tracks exercises. The Cheonan Production Factory expansion is also completed, taking the facility to 22,480 m² across multiple floors. InBody also opens its European subsidiary in the Netherlands.

2018

InBody's BPBIO320 sphygmomanometer becomes the first Korean blood pressure monitor to pass the European Society of Hypertension (ESH) clinical validation.

2019

InBody Mexico is established, expanding the company's Latin American footprint.

2020

InBody opens its U.K. subsidiary to serve the British and Irish markets directly.

2021

InBody establishes the Jinshan factory in China (InBody China Medical Technology) for regional production.

2023

InBody launches three new subsidiaries: InBody Oceania (Australia), InBody BWA (United States), and InBody Asia Pte. (Singapore). The next-generation InBody S-series and BWA 2.0 platforms are also released.

2024

InBody establishes its Vietnam subsidiary, deepening its presence across Southeast Asia.

2026

InBody is now present in 110+ countries with more than 180 million tests recorded globally. InBody India serves 1,500+ hospital, gym, and corporate wellness clients across 100+ Indian cities.

Person using an InBody device

Company Values

Education

Focusing on weight loss alone is not enough. We're moving the conversation away from BMI and weight loss and teaching the public on the importance of fat loss and muscle gain.

Motivation

Making healthy choices is hard enough as it is. We seek to help businesses motivate their own clients on how to transform their lifestyle to create healthier and happier people.

Actionable Insight

The InBody Result Sheet is specifically designed to give you the outputs you need to see which diets and exercises are clearly working for you. Our cutting-edge technology takes the guesswork out.

Innovation

We continuously push ourselves to be better than yesterday to create a better world for today and the generations to come. We're looking to the future with every new product that is produced.

CES Innovation Award 2015 — InBody BAND CES Innovation Award 2017 — InBody Watch iF Design Award 2015 — InBody 770 InBody CES Innovation Award Red Dot Design Award 2014 — InBody 570

InBody’s Story in India

From a 1996 Korean startup to a presence across 110+ countries — here’s how InBody arrived in India and what we deliver to hospitals, gyms, and corporate wellness programs nationwide.

Official Indian Subsidiary

InBody India

InBody India Pvt. Ltd. is the official Indian subsidiary of InBody Co., Ltd. (South Korea). Headquartered in Mumbai, we bring InBody's medical-grade BIA technology directly to hospitals, fitness centers, research institutes, and corporate wellness programs across India.

Our team provides end-to-end support — from device selection and installation to staff training, service, and data interpretation. Every InBody device sold through InBody India comes with full manufacturer warranty and dedicated in-country technical support.

1,500+
Test centers across India
100+
Cities served
500+
Hospital & clinic clients
98%
DEXA correlation

Head Office — Mumbai

SF-B-03, B Wing, 2nd Floor,
Art Guild House, Phoenix Market City,
L.B.S Marg, Kurla West,
Mumbai 400070, Maharashtra

Sectors We Serve in India

  • Multispecialty hospitals, research institutes & medical colleges
  • Premium gyms, fitness chains & sports science centers
  • Corporate wellness programs & occupational health
  • Bariatric surgery, dialysis & metabolic clinics
  • Government health schemes & nutrition programs